ImmunoGen (IMGN) Prices 6.25M Offering at $16/Share

Article Stock Quotes (1) Comments (0)

ImmunoGen, Inc. (Nasdaq: IMGN) announced today that it has priced an underwritten public offering of 6.25 million shares of its common stock at a price to the public of $16 per share. Gross proceeds are expected to be approximately $100 million, before deducting the underwriting discounts and commissions and offering expenses payable by ImmunoGen. The offering is expected to close on or about July 17, 2012, subject to satisfaction of customary closing conditions. ImmunoGen has granted the underwriters a thirty (30) day option to purchase up to 937,500 additional shares.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• BioLineRx (BLRX) Enters $20M ATM Offering w/ Stifel
• Tesla (TSLA) convertible note sale raised from $525 million to $600 million - DJ
• Arkansas Best (ABFS) Changes Nonunion DB Pension Plan; Sees Material Impact

Create E-mail Alert Related Categories

Corporate News, Equity Offerings

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?